These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17270032)

  • 1. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma.
    Ito A; Fujioka M; Yoshida T; Wakamatsu K; Ito S; Yamashita T; Jimbow K; Honda H
    Cancer Sci; 2007 Mar; 98(3):424-30. PubMed ID: 17270032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes.
    Suzuki M; Shinkai M; Honda H; Kobayashi T
    Melanoma Res; 2003 Apr; 13(2):129-35. PubMed ID: 12690295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
    Sato M; Yamashita T; Ohkura M; Osai Y; Sato A; Takada T; Matsusaka H; Ono I; Tamura Y; Sato N; Sasaki Y; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    J Invest Dermatol; 2009 Sep; 129(9):2233-41. PubMed ID: 19295615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
    Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
    Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
    Shinkai M; Yanase M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
    Jpn J Cancer Res; 1996 Nov; 87(11):1179-83. PubMed ID: 9045948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
    Ito A; Tanaka K; Kondo K; Shinkai M; Honda H; Matsumoto K; Saida T; Kobayashi T
    Cancer Sci; 2003 Mar; 94(3):308-13. PubMed ID: 12824927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
    Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
    Int J Cancer; 2005 Sep; 116(4):624-33. PubMed ID: 15825167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
    Sato A; Tamura Y; Sato N; Yamashita T; Takada T; Sato M; Osai Y; Okura M; Ono I; Ito A; Honda H; Wakamatsu K; Ito S; Jimbow K
    Cancer Sci; 2010 Sep; 101(9):1939-46. PubMed ID: 20594194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
    Ito A; Matsuoka F; Honda H; Kobayashi T
    Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vivo anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
    Yukitake J; Otake H; Inoue S; Wakamatsu K; Ito S
    Melanoma Res; 2004 Apr; 14(2):115-20. PubMed ID: 15057040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Sulfur Containing Melanogenesis Substrate,
    Tamura Y; Ito A; Wakamatsu K; Torigoe T; Honda H; Ito S; Jimbow K
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982309
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone.
    Kawai N; Futakuchi M; Yoshida T; Ito A; Sato S; Naiki T; Honda H; Shirai T; Kohri K
    Prostate; 2008 May; 68(7):784-92. PubMed ID: 18302228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
    Jimbow K
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.
    Kitagawa M; Nemoto T; Seki S; Ito S; Kasuga T
    J Cancer Res Clin Oncol; 1993; 119(8):470-4. PubMed ID: 8099588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
    Ito Y; Jimbow K
    Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
    Inoue S; Hasegawa K; Wakamatsu K; Ito S
    Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase.
    Parsons PG; Favier D; McEwan M; Takahashi H; Jimbow K; Ito S
    Melanoma Res; 1991; 1(2):97-104. PubMed ID: 1823629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
    Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
    Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
    Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
    Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core.
    Kawai N; Ito A; Nakahara Y; Honda H; Kobayashi T; Futakuchi M; Shirai T; Tozawa K; Kohri K
    Prostate; 2006 May; 66(7):718-27. PubMed ID: 16425185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.